Published in Clin Infect Dis on March 15, 2012
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis (2013) 2.01
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Cleve Clin J Med (2013) 1.53
Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care (2015) 1.30
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother (2014) 1.19
Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study. BMC Infect Dis (2013) 1.16
Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes. Clin Microbiol Rev (2017) 1.15
Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis. BMC Infect Dis (2014) 1.04
Colistin for lung infection: an update. J Intensive Care (2015) 1.03
Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). Haematologica (2013) 0.99
Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria. Antimicrob Agents Chemother (2013) 0.97
Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways. Antimicrob Agents Chemother (2014) 0.94
Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance. Antimicrob Agents Chemother (2016) 0.94
Update on the Epidemiology, Treatment, and Outcomes of Carbapenem-resistant Acinetobacter infections. Chonnam Med J (2014) 0.91
New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale. Antimicrob Agents Chemother (2014) 0.90
Clinical management of infections caused by multidrug-resistant Enterobacteriaceae. Ther Adv Infect Dis (2013) 0.88
Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use. Pharmacotherapy (2015) 0.86
Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients. Antimicrob Agents Chemother (2015) 0.85
Editorial commentary: Closing the loop--a colistin clinical study to confirm dosing recommendations from PK/PD modeling. Clin Infect Dis (2012) 0.85
Clinical Outcomes Associated with Polymyxin B Dose in Patients with Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Rods. Antimicrob Agents Chemother (2015) 0.85
A review on colistin nephrotoxicity. Eur J Clin Pharmacol (2015) 0.84
How to treat VAP due to MDR pathogens in ICU patients. BMC Infect Dis (2014) 0.81
Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have? Crit Care (2014) 0.81
Tracking colistin-treated patients to monitor the incidence and outcome of carbapenem-resistant Gram-negative infections. Clin Infect Dis (2014) 0.81
Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother (2013) 0.81
Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review. J Res Pharm Pract (2015) 0.80
Treatment of ventilator-associated pneumonia and ventilator-associated tracheobronchitis in the intensive care unit. A national survey of clinicians and pharmacists in Saudi Arabia. Saudi Med J (2015) 0.80
Clinical Efficacy of Polymyxin Monotherapy versus Nonvalidated Polymyxin Combination Therapy versus Validated Polymyxin Combination Therapy in Extensively Drug-Resistant Gram-Negative Bacillus Infections. Antimicrob Agents Chemother (2016) 0.78
High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia. Ann Clin Microbiol Antimicrob (2015) 0.77
Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli. Antimicrob Agents Chemother (2015) 0.77
Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial. Ann Intensive Care (2016) 0.76
Preliminary method for direct quantification of colistin methanesulfonate by attenuated total reflectance Fourier transform infrared spectroscopy. Antimicrob Agents Chemother (2015) 0.75
Colistin: potential for dosage error. Clin Infect Dis (2012) 0.75
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa. BMC Infect Dis (2017) 0.75
Survival or Safety: Balancing act with Colistin. J Glob Infect Dis (2015) 0.75
Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric Patients. Balkan Med J (2016) 0.75
Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria. Infect Dis Ther (2015) 0.75
Nephrotoxicity and efficacy assessment of polymyxin use in 92 transplant patients. Antimicrob Agents Chemother (2013) 0.75
Nephrotoxicity in Patients with or without Cystic Fibrosis Treated with Polymyxin B Compared to Colistin. Antimicrob Agents Chemother (2017) 0.75
Pharmacokinetic/toxicodynamic analysis of colistin-associated acute kidney injury in critically ill patients. Antimicrob Agents Chemother (2017) 0.75
Nephrotoxicity of High and Conventional Dosing Regimens of Colistin: A Randomized Clinical Trial. Iran J Pharm Res (2017) 0.75
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies. Infection (2017) 0.75
Nebulized antibiotics in mechanically ventilated patients: a challenge for translational research from technology to clinical care. Ann Intensive Care (2017) 0.75
Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients. Infect Drug Resist (2017) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control (2008) 24.70
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med (2005) 23.85
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis (2009) 22.98
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis (2006) 7.36
Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis (1999) 5.90
The changing epidemiology of resistance. J Antimicrob Chemother (2009) 5.13
A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant (2008) 4.29
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob Agents Chemother (2011) 4.21
Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center. Clin Infect Dis (2009) 3.92
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother (2009) 3.62
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect (2005) 3.39
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis (2003) 3.37
Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. Chest (2010) 2.92
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother (2005) 2.47
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care (2003) 2.38
A reassessment of the in-vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother (1997) 2.37
Does this patient have ventilator-associated pneumonia? JAMA (2007) 2.03
Back to the future: using aminoglycosides again and how to dose them optimally. Clin Infect Dis (2007) 1.92
Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis (2003) 1.89
Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect (2008) 1.82
Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit. Crit Care Med (2009) 1.64
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med (2005) 1.51
Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents (2005) 1.36
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections. Int J Antimicrob Agents (2009) 1.32
Predictors of acute kidney injury associated with intravenous colistin treatment. Int J Antimicrob Agents (2010) 1.26
Dosing of colistin-back to basic PK/PD. Curr Opin Pharmacol (2011) 1.20
Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur J Clin Microbiol Infect Dis (2006) 1.13
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive Care Med (2007) 1.13
Early acute kidney injury is a risk factor that predicts mortality in patients treated with colistin. Nephron Clin Pract (2010) 1.11
Colistin interactions with the mammalian urothelium. Am J Physiol Cell Physiol (2003) 1.10
Risk factors for colistin-associated nephrotoxicity. J Infect (2010) 1.04
Serum bactericidal activity of three different dosing regimens of colistin with implications for optimum clinical use. J Chemother (2010) 1.03
Pharmacokinetic evaluation of colistin sodium. Expert Opin Drug Metab Toxicol (2010) 1.00
Effects of polymyxin B on mammalian urinary bladder. J Membr Biol (1996) 0.90
Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA (2009) 6.55
Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med (2005) 4.61
Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med (2004) 2.56
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med (2006) 2.26
Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med (2007) 1.73
Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease. Crit Care Med (2007) 1.73
A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med (2006) 1.62
Superior mesenteric artery blood flow modifications during off-pump coronary surgery. Ann Thorac Surg (2006) 1.48
Low respiratory rate plus minimally invasive extracorporeal Co2 removal decreases systemic and pulmonary inflammatory mediators in experimental Acute Respiratory Distress Syndrome. Crit Care Med (2014) 1.44
ARDSnet ventilatory protocol and alveolar hyperinflation: role of positive end-expiratory pressure. Am J Respir Crit Care Med (2007) 1.41
Oral nystatin prophylaxis in surgical/trauma ICU patients: a randomised clinical trial. Crit Care (2012) 1.40
A new semiquantitative method of quantifying Helicobacter pylori in antigen stools. J Clin Gastroenterol (2002) 1.39
Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care (2013) 1.29
Haemodynamic goal-directed therapy and postoperative infections: earlier is better. A systematic review and meta-analysis. Crit Care (2011) 1.15
Anisakis pegreffi etiological agent of gastric infections in two Italian women. Foodborne Pathog Dis (2009) 1.13
Jaundice in critical illness: promoting factors of a concealed reality. Intensive Care Med (2006) 1.08
RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit. Blood Purif (2011) 1.05
Intra-abdominal hypertension in cardiac surgery. Interact Cardiovasc Thorac Surg (2013) 1.02
Management of descending duodenal injuries secondary to laparoscopic cholecystectomy. Dig Surg (2008) 1.01
The effects of goal-directed fluid therapy based on dynamic parameters on post-surgical outcome: a meta-analysis of randomized controlled trials. Crit Care (2014) 1.00
Haemodynamic goal-directed therapy in cardiac and vascular surgery. A systematic review and meta-analysis. Interact Cardiovasc Thorac Surg (2012) 0.96
Patient-requested neuraxial analgesia for labor: impact on rates of cesarean and instrumental vaginal delivery. Anesthesiology (2007) 0.92
Cerebro-pulmonary interactions during the application of low levels of positive end-expiratory pressure. Intensive Care Med (2005) 0.91
Bacteroides thetaiotaomicron in posthysterectomy infection. Anaerobe (2006) 0.90
Rapid recovery of Mycobacterium tuberculosis complex from clinical specimens using the BACTEC 9000 MB system, a new automated fluorimetric technique. Clin Microbiol Infect (1997) 0.90
Claritromycin resistance and Helicobacter pylori genotypes in Italy. J Microbiol (2006) 0.89
Utilization of small changes in serum creatinine with clinical risk factors to assess the risk of AKI in critically lll adults. Clin J Am Soc Nephrol (2014) 0.89
Antimicrobial profiles of Prevotella spp. and Fusobacterium nucleatum isolated from periodontal infections in a selected area of southern Italy. Int J Antimicrob Agents (2007) 0.89
Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice. Pain (2011) 0.88
Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg (2004) 0.87
Induction of mitochondrial dysfunction and oxidative stress in human fibroblast cultures exposed to serum from septic patients. Life Sci (2012) 0.87
Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation. Curr Clin Pharmacol (2013) 0.86
Candida colonization index in patients admitted to an ICU. Int J Mol Sci (2011) 0.85
A national survey of Italian physicians' attitudes towards end-of-life decisions following the death of Eluana Englaro: reply to M.Y. Rady. Intensive Care Med (2011) 0.85
Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities. BMC Infect Dis (2013) 0.84
Aeromonas sobria sepsis complicated by rhabdomyolysis in an HIV-positive patient: case report and evaluation of traits associated with bacterial virulence. Int J Infect Dis (2008) 0.83
Prevalence and genotypes identification of human papillomavirus infection in a population of South Italy. J Clin Virol (2008) 0.83
Extensive investigation of antimicrobial resistance in Vibrio parahaemolyticus from shellfish and clinical sources, Italy. Int J Antimicrob Agents (2013) 0.83
Amoebic hepatic abscesses in an HIV-positive patient. AIDS Patient Care STDS (2006) 0.82
A national survey of Italian physicians' attitudes towards end-of-life decisions following the death of Eluana Englaro. Intensive Care Med (2011) 0.82
Postoperative pain relief after surgical removal of impacted third molars: a single-blind, randomized, controlled study to compare levobupivacaine and mepivacaine. J Orofac Pain (2009) 0.81
Vitamin D and infectious diseases. Endocr Metab Immune Disord Drug Targets (2014) 0.81
Cytoreductive surgery combined with intraperitoneal chemohyperthermia for the treatment of advanced colon cancer. World J Surg (2006) 0.80
A case of descemet's membrane rupture in a patient affected by Acanthamoeba Keratitis. Eye Contact Lens (2009) 0.80
Direct detection of Mycobacterium tuberculosis complex in pulmonary and extrapulmonary samples by BDProbeTec ET system. New Microbiol (2005) 0.80
Rapid and sensitive detection of bla KPC gene in clinical isolates of Klebsiella pneumoniae by a molecular real-time assay. Springerplus (2013) 0.79
Simultaneous detection of viruses and Toxoplasma gondii in cerebrospinal fluid specimens by multiplex polymerase chain reaction-based reverse hybridization assay. New Microbiol (2009) 0.78
PMX endotoxin removal in the clinical practice: results from the EUPHAS trial. Contrib Nephrol (2010) 0.78
Streptococcus pneumoniae meningitis in a child vaccinated with pneumococcal heptavalent conjugate vaccine. New Microbiol (2009) 0.78
Environmental contamination by dog’s faeces: a public health problem? Int J Environ Res Public Health (2012) 0.78
Characterization of methicillin resistant Staphylococcus aureus (MRSA) isolated at the Policlinico Hospital of Bari (Italy). New Microbiol (2005) 0.78
Microbiological findings in endometrial specimen: our experience. Arch Gynecol Obstet (2011) 0.77
Detection of human papilloma virus in women attending the IRCCS, Ospedale oncologico Bari, Southern Italy: preliminary data. New Microbiol (2006) 0.77
Transesophageal echocardiography for diagnosis of traumatic aortic injury: an appraisal of the evidence. J Trauma (2004) 0.76
Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation. Author's response. Crit Care (2013) 0.75
Tuberculous otitis media with facial paralysis: a clinical and microbiological diagnosis-a case report. Case Rep Infect Dis (2011) 0.75
Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: possible role of LPS-binding protein. Crit Care (2014) 0.75
Epidemiological and virological investigation of a Norovirus outbreak in a resort in Puglia, Italy. BMC Infect Dis (2007) 0.75
The source of Helicobacter pylori infection in the neonatal period. J Perinat Med (2009) 0.75
Association between endotoxin activity and acute kidney injury in cardiac patients undergoing cardiopulmonary bypass. Blood Purif (2014) 0.75
Evaluation of the appropriateness of hepatitis B serology testing prescribed by general practitioners in a selected area of southern Italy. J Eval Clin Pract (2007) 0.75
Typhoid Fever in Italy, 2000-2006. J Infect Dev Ctries (2008) 0.75
A case of sympathetic ophthalmia after a severe acanthamoeba keratitis. Eye Contact Lens (2011) 0.75
Abdominal compartment syndrome: a situation thet needs to be better known. Chir Ital (2008) 0.75
Intraoperative hyperthermic tissue ablation in pulmonary metastases: a case report. Tumori (2004) 0.75
Ramirez's abdominoplasty technique combined with intraperitoneal chemohyperthermia after surgical cytoreductive procedures for the treatment of advanced intraperitoneal cancer in patients with ventral hernia. Ann Plast Surg (2010) 0.75
Paecilomyces lilacinus Keratitis in a Soft Contact Lens Wearer. Eye Contact Lens (2016) 0.75
Helicobacter pylori detection by stool antigen test in the perinatal period: an inadequate approach to establish maternal transmission. J Pediatr Gastroenterol Nutr (2008) 0.75
Perioperative hemodynamic goal-directed therapy and mortality: a systematic review and meta-analysis with meta-regression. Minerva Anestesiol (2016) 0.75
Utility of gas chromatography for rapid identification of mycobacterial species frequently encountered in clinical laboratory. J Microbiol Methods (2006) 0.75
Does the journey toward efficacy and safety of high dose beta-lactams pass through therapeutic drug monitoring? Minerva Anestesiol (2016) 0.75
Relapsing brucellosis related to pacemaker infection. Ital Heart J (2005) 0.75